Document Detail


Histochemical assay of estrogen and progesterone receptors in breast cancer: correlation with biochemical assays and patients' response to endocrine therapies.
MedLine Citation:
PMID:  6256056     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Estrogen (ER) and progesterone (PgR) receptors were assayed by histochemistry in primary, recurrent, and metastatic breast cancer. Ligand-conjugates composed of 17 beta-estradiol and 11 alpha-hydroxyprogesterone covalently linked to bovine serum albumin and labelled with fluorescein isothiocyanate were employed. Results were compared with those of conventional biochemical receptor assays and correlated for ER in 92% of 314 tumors and for PgR in 86% of 86 specimens. ER and PgR determinations by both assay systems were correlated with clinical response to various endocrine therapies in 40 women with Stage IV disease. The histochemical assay enabled successful prediction of response in 80% of cases including eight which could not be fully analyzed biochemically.
Authors:
L P Pertschuk; E H Tobin; E Gaetjens; A C Carter; G A Degenshein; N D Bloom; D J Brigati
Related Documents :
9049186 - Ddt mimicks estradiol stimulation of breast cancer cells to enter the cell cycle.
19150946 - Role of biologic therapy and chemotherapy in hormone receptor- and her2-positive breast...
19381686 - Association of hormone receptor status with grading, age of onset, and tumor size in br...
1567686 - Heterogeneity of oestrogen receptor expression in normal and malignant breast tissue.
16856936 - Promiscuity in multidrug recognition and transport: the bacterial mfs mdr transporters.
24713546 - The clinical and diagnostic role of micrornas in ovarian carcinoma.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Cancer     Volume:  46     ISSN:  0008-543X     ISO Abbreviation:  Cancer     Publication Date:  1980 Dec 
Date Detail:
Created Date:  1981-03-17     Completed Date:  1981-03-17     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0374236     Medline TA:  Cancer     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  2896-901     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenalectomy
Binding, Competitive
Breast Neoplasms / analysis*,  therapy
Carcinoma, Intraductal, Noninfiltrating / analysis,  therapy
Castration
Centrifugation, Density Gradient
Diethylstilbestrol / therapeutic use
Female
Fluorescent Antibody Technique
Fluoxymesterone / therapeutic use
Histocytochemistry
Humans
Neoplasm Metastasis
Receptors, Estrogen / analysis*
Receptors, Progesterone / analysis*
Tamoxifen / therapeutic use
Grant Support
ID/Acronym/Agency:
CA23623/CA/NCI NIH HHS; N01-CN-45139/CN/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Receptors, Estrogen; 0/Receptors, Progesterone; 10540-29-1/Tamoxifen; 56-53-1/Diethylstilbestrol; 76-43-7/Fluoxymesterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Correlation of hormone receptors with pathological features in human breast cancer.
Next Document:  Steroid receptor interactions in human breast carcinoma.